Loading stock data…
Senseonics Holdings (SENS)
$5.94+0.22 (+3.85%)
After Hours$5.94+0.00 (+0.00%)· Last close Jun 29
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Senseonics Holdings, Inc. in the Healthcare sector is trading at $5.94 with a market capitalization of $378M. Wall Street consensus targets $13.80 (5 analysts), implying a +132.3% move over the next 12 months. The stock is currently near its 52-week low of $4.79, remaining 14.8% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +132.3% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 31) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $11.71M↓ | $14.26M↑ | $8.10M↑ | $6.65M↑ | $6.26M |
| Gross Profit | $6.94M↓ | $7.67M↑ | $3.47M↑ | $3.12M↑ | $1.50M |
| Operating Income | -$31.85M↓ | -$20.93M↓ | -$19.60M↓ | -$14.32M↓ | -$13.49M |
| Net Income | -$32.33M↓ | -$20.82M↓ | -$19.53M↓ | -$14.50M↓ | -$14.26M |
Peer Comparison
JNJUNHPFE
Fundamentals
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$377.95M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-253.93%
Volume
Today's trading volume
607,409
Recent News
Strength Seen in Senseonics (SENS): Can Its 6.1% Jump Turn into More Strength?
Senseonics (SENS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Senseonics Holdings, Inc. Common Stock Q1 Earnings Call Highlights
Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) raised its full-year 2026 revenue outlook after reporting first-quarter growth tied to adoption of its Eversense 365 continuous glucose monitoring system and the integration of its U.S. commercial organization. President and CEO Tim Goodnow said
Senseonics Holdings (SENS) Reports Q1 Loss, Beats Revenue Estimates
Senseonics (SENS) delivered earnings and revenue surprises of -9.23% and +16.81%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Top Midday Decliners
BayFirst Financial's (BAFN) shares sank 28% after the company reported a wider Q1 loss and lower rev
Study Supports GlucoTrack’s Blood Glucose Monitoring Implant
By Karen Roman GlucoTrack, Inc. (Nasdaq: GCTK) said a peer-reviewed study published in the Institute of Electrical and Electronics Engineers Sensors Journal supported the feasibility of long-life implantable continuous glucose monitors like the devices the company develops. The article came out on April 7, 2026, and is the result of a partnership between GlucoTrack and […]